申请人:MERZ PHARMA GMBH & CO KGAA
公开号:WO2010139483A1
公开(公告)日:2010-12-09
The invention relates to pyrazolopyrimidine derivatives as well as their pharmaceutically acceptable salts. The invention further relates to a process for the preparation of such compounds. The compounds of the invention are glycine B antagonists and are therefore useful for the control and prevention of various disorders, including neurological disorders.
该发明涉及吡唑吡咪啉衍生物及其药用可接受的盐。该发明进一步涉及一种制备这种化合物的方法。该发明的化合物是甘氨酸B拮抗剂,因此可用于控制和预防各种疾病,包括神经系统疾病。